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A number of important changes take place in the maternal uterine vasculature during the ﬁrst few weeks
of pregnancy resulting in increased blood ﬂow to the intervillous space. Vascular endothelial and smooth
muscle cells are lost from the spiral arteries and are replaced by fetal trophoblast cells. Failure of the
vessels to remodel sufﬁciently is a common feature of pregnancy pathologies such as early pregnancy
loss, intrauterine growth restriction and pre-eclampsia. There is evidence to suggest that some vascular
changes occur prior to trophoblast invasion, however, in the absence of trophoblasts remodelling of the
spiral arteries is reduced. Until recently our knowledge of these events has been obtained from immu-
nohistochemical studies which, although extremely useful, can give little insight into the mechanisms
involved. With the development of more complex in vitro models a picture of events at a cellular and
molecular level is beginning to emerge, although some caution is required in extrapolating to the in vivo
situation. Trophoblasts synthesise and release a plethora of cytokines and growth factors including
members of the tumour necrosis factor family. Studies suggest that these factors may be important in
regulating the remodelling process by inducing both endothelial and vascular smooth muscle cell
apoptosis. In addition, it is evident from studies in other vascular beds that the structure of the vessel is
inﬂuenced by factors such as ﬂow, changes in the composition of the extracellular matrix, the phenotype
of the vascular cells and the local immune cell environment. It is the aim of this review to present our
current knowledge of the mechanisms involved in spiral artery remodelling and explore other possible
pathways and cellular interactions that may be involved, informed by studies in the cardiovascular ﬁeld.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
In human pregnancy fetal trophoblast cells invade into the wall
of the uterus in a tightly regulated manner. Cytotrophoblast cell
columns form from the tips of anchoring villi and a shell develops
from which extravillous trophoblasts invade into the decidua.
Interstitial extravillous invasion occurs through the decidua with
interstitial cells reaching the superﬁcial myometrium by the eighth
week of gestation [1]. Endovascular extravillous invasion arises as
cells from the cytotrophoblastic shell invade the uterine spiral
arteries from sites where they lie over the distal openings of the
vessels, with endovascular cells detectable in decidual segments of
the spiral arteries from approximately 8 weeks but especially after
10 weeks [2]. Invasion by extravillous trophoblast causes a tempo-
rary plugging of spiral arteries, decreasing ﬂow of maternal blood
whichmay protect the fetus from oxidative stress [3]. Dissolution of
these plugs may trigger further trophoblast invasion [4] and, fromfax: þ44 020 8725 2992.
ey).
All rights reserved.14 weeks, endovascular trophoblast can be seen in deeper spiral
artery segments of the inner myometrium [5].
The blood supply to the uterus comprises a branched structure
with successive decreases in vessel diameter as they progress
through the myometrium and endometrium. Spiral arteries, so
called because of their coiled appearance, supply blood to the
endometrial layer and, in the pregnant uterus, span the inner
myometrium and the decidua. During pregnancy the placental bed
spiral arteries are transformed from high-resistance, low-ﬂow
vessels into large dilated vessels with an increased blood ﬂow at
a much reduced pressure [6]. These alterations occur as a result of
loss of smooth muscle cell and elastic lamina from the vessel wall.
The endothelium is temporarily replaced with a trophoblast layer,
although it is restored later in pregnancy. The lumen of the
remodelled vessel is dilated and there is trophoblast deposition of
a ﬁbrinoid matrix in the vessel wall; together these alterations are
termed “physiological change” [7].
In resistance vessels such as the spiral artery, vascular smooth
muscle cells (VSMC) are coiled round a central lumen formed by
a single layer of endothelial cells (EC). At the distal end of spiral
arterioles the wall is formed from a single layer of VSMC while in
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spiral arteries have a luminal diameter of approximately 200 mm [8]
while remodelled vessels at the point of discharge into the inter-
villous space can attain a diameter of 2 mm [9]. These dramatic
changes to the vessel architecture result in a tenfold increase in the
blood supply to the fetoplacental unit in the third trimester
compared to the non-pregnant uterus [10]. It is thought that
virtually all 100e150 arteries in the placental bed are transformed
[11] with spiral arteries at the centre of the placenta being more
extensively remodelled than those at the periphery [7]. How our
knowledge of the changes that occur at the fetalematernal inter-
face has developed together with some of the controversies in the
ﬁeld have been extensively reviewed elsewhere [4,12].
2. Trophoblast invasion and spiral artery remodelling
Extravillous trophoblast invasion can either be interstitial
through the decidua or endovascular via the distal ends of the spiral
arteries where invasion occurs retrograde to blood ﬂow. In the
study of spiral artery remodelling immunohistochemical studies
have been informative; however, a number of questions remain
unanswered regarding the relative importance played by the
different routes of trophoblast invasion [4]. Decidua-associated
vascular remodelling, including endothelial vacuolation and VSMC
swelling, occurs prior to trophoblast invasion andmay be under the
control of the same factors responsible for initial changes in the
decidua, such as steroid hormones. Recent immunohistochemical
studies indicate that immune cells may play a role at this stage [13].
These changes are followed by interstitial trophoblast invasion
which, it is suggested, inﬂuences the cells of the vessel wall by
preparing them for subsequent endovascular invasion [5]. This
concept is supported by studies of decidual vessels [14] where it
was shown that medial disruption only occurred when interstitial
trophoblast were present around the vessel. Conceptually, an initial
interaction of interstitial trophoblast with VSMC is logical given the
location of the cells, and is supported by observations that smooth
muscle cells were lost from the external layers of the vessel media
ﬁrst [14]. In this context, the effects on medial organisation and
extracellular matrix proteins may be particularly important.
Trophoblast invasion occurring via the endovascular route would
facilitate initial interactions with the endothelium. Indeed,
trophoblast and endothelial cells have been shown to transiently
co-exist in vessels undergoing remodelling [15]. Following the loss
of the endothelium these endovascular trophoblasts would then be
positioned to further inﬂuence medial VSMC.
It has been a matter of some debate as to whether the endo-
vascular trophoblast has a route of invasion that is separate and
distinct from the interstitial trophoblast. It has been suggested that
the endovascular trophoblast arises from the interstitial tropho-
blast invading through the vessel wall, rather than migration
intraluminally [16]. This theory has been reﬁned to suggest that,
although this may be the case in the more superﬁcial decidua, it is
unlikely to account for the presence of endovascular cells further
into the myometrium where there are many fewer perivascular
interstitial cells [4]. A combination of both routes may, therefore, be
important, with their relative input determined by where the
invasion is taking place spatially within the placental bed.
Regardless of the route, it has been well established that
trophoblast invasion can be inﬂuenced by a plethora of regulating
factors such as cytokines and growth factors, adhesion molecules,
matrix metalloproteinases (MMPs) and oxygen tension (reviewed
by Lunghi et al. [17]). In addition, the local cellular environment will
inﬂuence this (for example, maternal immune cells present in the
decidua such as macrophages and decidual natural killer cells)
either through direct interactions or by secretion of soluble factors.These factors not only inﬂuence the invasive process but also
inﬂuence the phenotype of the trophoblast, for instance immuno-
histochemical studies suggest that there are changes in trophoblast
expression of various adhesion molecules as they near spiral
arteries, perhaps in preparation for their interaction with and
replacement of the vascular cells [18]. The orchestrated movement
of trophoblasts is illustrated by in vitro co-culture studies which
demonstrate that trophoblast migration towards vascular cells is
directional [19] and that trophoblasts preferentially target arteries
rather than veins [20].
3. Impaired remodelling in pre-eclampsia
In pregnancies complicated by the common pregnancy disorder
pre-eclampsia, remodelling is restricted to the decidual regions of
the spiral arteries [21]. The altered uteroplacental haemodynamics,
as a consequence of impaired vessel remodelling, has been impli-
cated as a contributing factor to the pathology of this syndrome.
Similar deﬁciencies have also been described in spiral arteries of
women with small-for-gestational-age infants [22].
Impaired invasion is likely to be a component of pre-eclampsia
but with potential differences in the interstitial versus endovas-
cular cells. Interstitial invasion did not appear impaired in initial
studies [23], suggesting that defects may exist in the endovascular
trophoblast invasion pathway, although subsequently less inter-
stitial invasion has been reported [24,25]. This highlights the
importance of characterising the interactions with spiral arteries
since, even if there is sufﬁcient invasion in some cases, then there
could be a primary deﬁciency in how trophoblast are able to prime
or interact with and remodel the vessels.
4. Problems in studying spiral artery remodelling in human
pregnancies
There are a number of difﬁculties in studying the mechanism of
human spiral artery remodelling. The process occurs over a number
of weeks yet, under normal circumstances, material can only be
accessed at term or following ﬁrst or early second trimester
terminations of pregnancy. As interventional mechanistic studies in
humans are clearly impossible researchers have turned to animal
models. Although the rodent model has proved useful there are
limitations due to signiﬁcant differences in both the depth of
trophoblast invasion and the extent of spiral artery remodelling
observed compared to human pregnancy. Studies of normal and
ectopic pregnancies have provided valuable insights into tropho-
blast dependent and independent changes in spiral artery structure
[14,26] but still provide little or no molecular clue as to the
regulation of this important process.
Placental cells from term pregnancies and vessels from uterine
biopsies taken during caesarean section or hysterectomy are
available, however, their use to model events in the ﬁrst few weeks
of pregnancies is problematic. Cells derived from tissue at this stage
will have been exposed to different stimuli and stresses and so may
respond very differently to cells from the ﬁrst trimester. Even
within the ﬁrst trimester, gestational related differences in cellular
behaviour have been reported. For example trophoblasts isolated
from weeks 8 to 10 are intrinsically more invasive than those iso-
lated from 10 to 12 or 12 to 14 weeks gestation [27]. Interpretation
of data from the ﬁrst trimester is further complicated as a propor-
tion of these pregnancies would have developed clinical compli-
cations had the pregnancy gone to term. A recent advance in the
screening of early pregnancies by uterine artery Doppler ultra-
sound is starting to address this [28]. First trimester placental cells
can now be isolated from pregnancies characterised according to
their risk of developing pre-eclampsia. Using such an approach
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Screening of this nature will provide an extra dimension to the data
obtained from ﬁrst trimester material.
Studies using primary cells isolated from their in vivo environ-
ment or cell lines derived from them have been invaluable in
elucidating functional aspects of trophoblast invasion and their
interaction with vascular cells that would have been impossible to
determine immunohistochemically. However, isolation and
subsequent monolayer culture destroys three dimensional inter-
actions with thematrix and neighbouring cells whichmay alter cell
behaviour. For example, the trophoblast phenotype when it inter-
acts with cells of the spiral artery will be the end result of
complicated signalling events as invasion occurs; this will be
difﬁcult to recreate in cell culture studies. In recent years a number
of groups, including our own, have attempted to overcome these
problems by developing in vitro culture models using different
matrices and formats including spheroidal cultures [31,32],
complex co-cultures of different cell types and 3D explant models
[33,34] which, in combination with the immunohistochemical
approach, should prove particularly powerful [35]. In most of the
published models trophoblast and vessels will be obtained from
different patients although some attempts have been made to
address this with combined chorionic villous and decidual explant
cultures from the same patient [34]. In the following sections we
will describe the results obtained using these models and, where
appropriate, discuss any difﬁculties in the interpretation of the
results and extrapolating to the in vivo situation.
5. Possible mechanisms of spiral artery remodelling
Although the details have yet to be established, several mech-
anisms may be involved in the changes that occur to the vascular
cells and their immediate environment. These include extracellular
matrix restructuring, vascular cell de-differentiation, migration,
changes in cellular adhesion and sensitivity to death-inducing
stimuli. These events are not mutually exclusive and may be
interdependent, although one mechanism may be more important
for the removal of VSMC than EC or vice versa. Some of these
processes may be, in part or wholly, mediated through the actions
of the invading trophoblasts and the role played by endovascular
trophoblasts compared to interstitial trophoblasts may be different.
It is also clear that other cells, particularly those of the maternal
immune system, may play an important part in the process.
Remodelling could be further modulated by the changes in blood
ﬂow and pressure that occur during the early stages of pregnancy. It
is the aim of the remainder of this review to present our current
knowledge of themechanisms involved in spiral artery remodelling
using data obtained from a combination of immunohistochemical
studies and in vitromodels. Where appropriatewewill draw on the
knowledge gained fromvascular remodelling events that take place
in other vascular beds in response to a number of physiological and
pathophysiological scenarios and so highlight possible future
directions.
6. Apoptosis and spiral artery remodelling
Apoptosis plays a role in both normal vessel regression and
pathological vascular remodelling such as that seen in atheroscle-
rosis and thrombosis [36]. Apoptosis is asynchronous in nature and,
unlike necrosis, does not result in membrane disruption nor does it
elicit an inﬂammatory response, thereby preventing local tissue
damage. Apoptotic cells can be rapidly removed by neighbouring
cells and professional phagocytes such as macrophages.
The fate of individual EC and VSMC within a vessel lumen is
dependent on the balance between pro- and anti-apoptotic stimuli.In a quiescent vessel cell death is matched by proliferation. Cell
death in excess of proliferation can lead to vascular wall instability
as observed in pathological conditions such as aortic aneurism. In
the spiral artery, vascular cell loss is not achieved at the expense of
vessel integrity suggesting the mechanisms involved are tightly
regulated. The asynchronous nature of apoptosis would ﬁt with the
gradual remodelling of the spiral arteries seen in vivo.
A number of factors are known to inﬂuence the survival of EC
including growth factors, cytokines and cell adhesion. We propose
that invading trophoblasts alter the balance in the vessel towards
cell death, either directly via the paracrine release of apoptotic
factors, or indirectly by stimulating loss of cellular adhesion (a type
of apoptosis known as anoikis). As the cells of the vessel are in
a steady state, loss of the endothelium together with the presence
of the trophoblast could then induce VSMC death. Many of the
factors that inﬂuence both endothelial and VSMC survival are
present at the fetalematernal interface and may, therefore, play
a role in the remodelling of the spiral artery.
Three members of the tumour necrosis factor (TNF) family of
cytokines have been implicated in the regulation of vascular cell
apoptosis: tumour necrosis factor-a (TNFa), TNF-related apoptosis
inducing ligand (TRAIL) and Fas ligand (FasL). All of these factors are
expressed/produced by trophoblasts [37e41]. TNFa binds to and
activates two distinct receptors TNF-receptor 1 (TNF-R1) and
TNF-R2; both are expressed on EC and VSMC [42]. Activation of
TNF-R1 leads to recruitment of the intracellular adapter molecule
TNF-receptor-associated death domain (TRADD) together with
a number of proteins including TRAF2 (TNF-receptor-associated
factor 2). This transiently activates the JNK pathway and promotes
cell survival. However, if TRAF2 recruits the Fas activating death
domain (FADD), pro-caspase 8 undergoes cleavage and apoptosis is
induced. The overall balance between pro- and anti-apoptotic
factors present in the local environment determines which
pathway is activated.
It was once thought that only transformed cells were sensitive
to the effects of TRAIL; however, it is now clear that many cells
including those of the cardiovascular system express the receptors
on their cell surface and respond to TRAIL. TRAIL-receptor 1 (TRAIL-
R1; death receptor 4 (DR4)) and TRAIL-R2 (DR5) initiate apoptosis
and are expressed on EC and VSMC [41,43]. There are also two
decoy receptors (DcR1 and DcR2) which are expressed by EC from
different vascular beds [43e45]. Binding of TRAIL to the decoy
receptors does not induce apoptosis but may compete for TRAIL
binding with TRAIL-R1 and -R2 [46]. TRAIL is synthesised by ﬁrst
trimester cytotrophoblasts and extravillous-like trophoblast cell
lines [41], and both TRAIL-R1 and R2 are expressed on VSMC and to
a lesser extent on EC of ﬁrst trimester spiral arteries [41].
FasL binds to and activates the cell surface receptor Fas (CD95).
FasL has been detected at thematernalefetal interface [47] where it
is expressed by villous, extravillous and syncytiotrophoblast, and
was proposed to contribute to the immune privilege observed in
this uteroeplacental environment by inducing apoptosis of acti-
vated Fas-expressing maternal lymphocytes [48,49]. Fas expression
has been shown in both EC and VSMC of term spiral arteries [50],
however, a comprehensive investigation of its expression with
gestational age remains to be carried out.
Direct co-culture techniques have been used to determine
whether trophoblasts employ similar apoptotic mechanisms to
facilitate spiral artery remodelling. Both primary ﬁrst trimester
extravillous trophoblasts and extravillous-derived cell lines
induced caspase-dependent apoptosis of both EC and VSMC.
Transwell co-culture experiments and incubationwith trophoblast-
conditioned medium indicated that this effect was, at least in part,
mediated by soluble factors. FasL can be shed from the surface of
cells following the action of MMPs [51e53] but whether sFasL
G.St.J. Whitley, J.E. Cartwright / Placenta 31 (2010) 465e474468inhibits or stimulates apoptosis is an area of some debate [51,54].
We observed that a blocking antibody to FasL/sFasL inhibited VSMC
and EC death following culture with either trophoblast cells or
trophoblast conditioned media, indicating a role for sFasL in this
process [50,55].
In similar experiments TRAIL activation of both TRAIL-R1 and -R2
were shown to be involved in trophoblast-induced VSMC apoptosis
[41]. As with FasL, TRAIL can either be a membrane associated or
a soluble protein. The soluble form of TRAIL is released following
proteolytic cleavage of the carboxy-terminus by cysteine proteases.
However, in our studies although we could detect cell associated
TRAIL in trophoblasts, we were unable to detect soluble TRAIL
activity in trophoblast conditioned medium [56] or protein by
speciﬁc ELISA [41]. A similar role for TRAIL in VSMC apoptosis
induced by lymphocytes has been reported [57]; however, there is
some controversy as in contrast to this Kavurma et al. reported
increased VSMC proliferation in response to TRAIL rather than
apoptosis [58].
The most common EC used in vitro studies are derived from
human umbilical vein. It is now known that EC from different
vascular beds can behave differently. The most appropriate cells for
these studies would, therefore, be ﬁrst trimester spiral artery
endothelial cells, however, it has not yet possible to isolate these
cells in sufﬁcient numbers. Cells obtained from ﬁrst trimester
decidua can be isolated but they are a mixture of spiral artery
endothelial cells and cells from other decidual vessels. In the
studies detailed above both human umbilical vein endothelial cell
lines and ﬁrst trimester decidual endothelial cells were used and
the results compared. No signiﬁcant differences in the responses
were observed [50].
In order to overcome some of the limitations in the use of in
vitro models study the complex 3D environment we have
employed the use of a more physiological model. Spiral arteries
were dissected from the non-placental bed biopsies obtained at
term from women undergoing caesarean section. These vessels
were chosen as they would have undergone normal decidual
remodelling but would not have been exposed to trophoblast,
although clearly being vessels from term placenta will mean there
are some differences to the vessels in the ﬁrst trimester. Short
segments of artery were perfused either with ﬁrst trimester
extravillous trophoblasts or trophoblast-conditioned medium for
up to 72 h; the vessels were sectioned and stained for endothelial,
VSMC or apoptotic markers. Perfusion of spiral arteries with
trophoblasts and trophoblast conditioned medium lead to EC and
VSMC loss by apoptosis [50,55]. Cell death was inhibited by caspase
inhibitors and blocking antisera to FasL and TRAIL-R1 substanti-
ating the effects observed in co-culture studies [41,50,55]. Subse-
quently Red-Horse et al. have demonstrated similar results using an
in vivo model. In this study ﬁrst trimester chorionic villi were
transplanted to the mammary fat pads of SCID mice. After three
weeks, EC and VSMC apoptosis were detected in arterioles associ-
ated with trophoblast invasion [59].
Within the body there are efﬁcient mechanisms for the removal
of cells undergoing apoptosis. Phagocytosis is one such mechanism
known to be involved in the remodelling of other tissues. Dead and
dying cells can be removed within 1e2 h of the induction of
apoptosis [60e62] without apparent tissue damage. Apoptotic cells
can be removed either by their neighbours or by professional
phagocytes and, because cells are removed before the plasma
membrane is ruptured, the release of potentially toxic or immu-
nogenic intracellular contents is prevented. There are a number of
signals that an apoptotic cell utilises to signal to phagocytes,
including the phospholipid phosphatidylserine. The exposure of
phosphatidylserine on the outside of a cell is a very early feature of
apoptosis and precedes the nuclear events [63]. It is, therefore,apparent that cell clearance from tissues may occur before the
target cells have a chance to display other characteristic markers of
apoptosis [64]. In addition to professional phagocytes such as
macrophages which are present in the decidua, trophoblasts are
also phagocytic [65,66] and could play a signiﬁcant role in
removing dead and dying cells from the vessel. Other cells within
the vessel including both VSMC and EC possess similar activity. The
proﬁcient clearance of apoptotic vascular cells may explain why it
has proven difﬁcult to detect apoptosis within rapidly remodelling
tissues using an immunohistochemical approach [62,67]. However,
recent studies of sections of ﬁrst trimester decidua basalis have
demonstrated apoptotic markers in both spiral artery VSMC and EC
during the remodelling process [13]. As our knowledge of the
pathways and sequence of events improves through in vitro studies
there will undoubtedly be reﬁnements that can be made to the
snapshot immunohistochemical approach both in the timing of
obtaining tissue samples along with the detection of panels of
different markers. It is only when we have integrated information
from both the in vitro and the in vivo situation that we can get
a convincing picture of these important events; this is starting to be
the case for apoptotic events in the spiral artery vascular cells.
7. Extracellular matrix and vascular remodelling
The structural and functional integrity of the vessel is main-
tained by the extracellular matrix (ECM). This is a complex struc-
ture of variable composition synthesised and maintained in a state
of dynamic equilibrium by the tightly regulated activity of
proteolytic enzymes. The wall of the unmodiﬁed spiral artery is
formed of three distinct layers with the cells of the vessel lying on,
or embedded in the matrix. The intima consists of a single layer of
endothelial cells that lies on top of a basement membrane made
predominantly of collagen type-IV and laminins. The elastic lamina
forms a tightly woven layer of elastin and collagen type-IV ﬁbres
together with ﬁbronectin that surrounds the intima and separates
the EC and the VSMC providing strength, resilience, support and
passive recoil to the vessel wall. Small pores or fenestrae within the
matrix enable EC/VSMC to form direct cell to cell contact via
myoeendothelial junctions. In the decidual segments of the uterine
spiral arteries, the internal elastic lamina is reduced or is absent.
A second prominent layer of elastic ﬁbres surrounds the medial
VSMC forming the external elastic lamina. The adventitial layer
surround this and consists predominantly of collagen ﬁbres and
ﬁbroblasts [68,69]. Both the external elastic lamina and the
adventitia will act to impede the invading interstitial trophoblasts
while the basement membrane and the internal elastic lamina will
form a barrier to endovascular invasion and remodelling [70].
Changes in the structure of the spiral artery start before the
arrival of trophoblasts [14,26] and correlate with the presence of
maternal leukocytes [13]. The subsequent arrival of interstitial
trophoblast is associated with changes in the myometrial segment
of the spiral arteries including dilation of the lumen, intimal
oedema, disruption of the elastic lamina and widening of the
intercellular spaces of the media [5,71]. Further disorganisation of
the intima and media takes place following the arrival of the
endovascular trophoblasts which invade the sub-endothelial space
disrupting ECeEC interaction and degrading elastin [22,72]. The
proteolytic enzymes synthesised and released by both the vascular
cells and invading trophoblasts appear central to the remodelling of
the matrix. Prominent in this regard are the matrix metal-
loproteinases (MMPs), a family of zinc-dependent endopeptidases
which together degrade all components of the extracellular matrix.
MMPs are produced by EC (MMP-1 and -9), VSMC (MMP-2, -9, and
the elastase MMP-12), dNK, macrophages [13] and invasive extra-
villous trophoblasts (MMP-1, -2, -9 -12 and membrane-type MMP)
Table 1
Expression of MMPs and TIMPs by trophoblasts, immune and vascular cells.
MMP Enzyme Substrate Cell type
I Collagenase-1 Collagen type I, II, III, VII, VIII, X, MMP-2 and -9 EC reviewed [75]
iEVTa [76,77]
2 Gelatinase A Collagen type I, II, III, IV, V, VII, X, XI, elastin,
ﬁbronectin, MMP-9 and -13
VSMC (synthetic phenotype)b [78] reviewed [79,80]
EC reviewed [75,81]
iEVTa [82]
dNKa [83]
SGHPL-4 EVT cell line [84]
3 Stromolysin-1 Collagen type III, III, IV, IX, X, XI, elastin, ﬁbronectin,
laminin and MMP-7, -8 and -13
iEVTa [77,85]
SGHPL-4 EVT cell lineb [84,85]
7 Matrilysin-1 Collagen type IV, X, elastin, ﬁbronectin,
laminin and MMP-1, -2, and -9
dNK [13]
Macrophagea [82]
vEVTa [82]
9 Gelatinase B Collagen type IV, V, VII, X, XIV, elastin, ﬁbronectin VSMC (synthetic phenotype)b [86] reviewed [79,80]
EC reviewed [75,81]
Cytotrophoblastb [87e89]
vEVTa [82]
SGHPL-4 EVT cell line [84]
dNKa [13,83]
Macrophage [82]
10 Stromolysin-2 Collagen type III, IV, V elastin, ﬁbronectin,
laminin and MMP-1 and -8
VSMC reviewed [79,80]
EC reviewed [75,81]
12 Metalloelastase Collagen type IV, elastin, ﬁbronectin and laminin VSMC reviewed [79,80]
EVTb [90]
BeWo cell line [56]
13 Collagenase-3 Collagen type I, II, III, IV SGHPL-4 EVT cell line [84]
14 MT1-MMP Collagen type I, II, III, elastin, ﬁbronectin,
laminin, MMP-2 and -13
EVTa [91]
SGHPL-4 EVT cell line [84]
Cytotrophoblastb [87]
VSMC reviewed [79,80]
EC reviewed [81]
24 MT5-MMP Fibrin SGHPL-4 EVT cell line [84]
TIMP Inhibition Cell type
I All MMPs VSMCa,b [142]
EVTa [76,83]
Cytotrophoblastb [87]
iEVT [83]
dNK [83]
2 MMP-2 and MT1-MMP EC reviewed [81]
VSMCa,b [142]
iEVTa [77]
Cytotrophoblastb [87]
dNKa [83]
3 MT1-MMP dNKa [83]
Cytotrophoblastb [87]
iEVT: interstitial extravillous trophoblast, and vEVT: endovascular extravillous trophoblast.
a In vivo studies.
b In vitro studies.
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a serineeprotease with trypsin-like activity that degrades
a number of substrates including collagen IV and ﬁbronectin
[92,93] which may play an important role in the remodelling
process.
Trophoblasts can inﬂuence the synthesis of MMP-12 by VSMC
[56]. It remains to be determined whether this is an isolated effect
or whether trophoblasts can affect the synthesis and release of
other matrix degrading enzymes by VSMC or other cells within the
environment of the spiral artery. The action of MMPs on ECM will
not only affect the structure of the vessel wall but also cause the
release of a number of biologically active molecules. For example,
the activity of MMP-2 (expressed by both VSMC and extravillous
trophoblast) can release transforming growth factor-b (TGF-b)
bound to the ECM [94], while VEGF is released following the actionof MMP-9. TGF-b regulates trophoblast invasion and motility [95]
while VEGF is a known EC survival factor and may act to counter
the apoptotic effects of the trophoblast, thereby controlling the
extent of remodelling. Collagen XVIII is a minor component of the
spiral artery basement membrane produced by the EC and VSMC
[96]. Cleavage of collagen XVIII by MMP-2 or -9 releases endostatin,
which inhibits EC proliferation [97] and stimulates apoptosis
[98,99]. Both MMP-2 and -9 are expressed by the invading
trophoblast [100]. Similarly the breakdown of elastin releases
elastin-derived peptides which can induce the de-differentiation of
VSMC and stimulate leukocyte chemotaxis, however, the role these
molecules have in remodelling of spiral arteries has yet to be
established [70]. In addition to a possible role for MMPs, studies in
mice suggest that cysteine cathepsin 8, expressed by trophoblasts,
is involved in localised spiral artery remodelling by mediating
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remains to be determined.
The survival of both EC and VSMC is dependent on their inter-
action with the ECM and the generation of speciﬁc intracellular
signals. Loss of these matrix-derived signals through the direct
breakdown of the ECM, or the release of inhibitory peptides
following the breakdown of components of the ECM, can result in
the induction of a speciﬁc form of apoptosis known as anoikis.
However, apoptosis is not the only potential outcome of ECM
degradation as it can also regulate cellular migration, and indeed
elastase activity is associated with VSMC migration [102]. Whether
the effects of matrix degradation result in migration or cell loss will
no doubt depend on the extent and duration of the process. Factors
affecting this have yet to be addressed.
In normal pregnancies excessive MMP activity is believed to be
regulated by tissue inhibitors of matrix metalloproteinases (TIMPs)
[74] produced by decidual stromal cells, EC, VSMC and trophoblasts.
Although differences in both MMPs and TIMPs have been observed
in cytotrophoblasts [73,103], endothelial cells [104] and maternal
serum [105,106] of pregnancies complicated with pre-eclampsia
direct extrapolation back to events occurring at the fetal/maternal
interface in the ﬁrst trimester may not be appropriate.
8. Fibrinoid deposition
A characteristic of the ‘physiologic change’ is the secretion of
ﬁbrinoid material composed of ﬁbronectin, collagen type IV and
laminin by extravillous trophoblasts [7,107]. Although this resem-
bles the basement membrane, secretion is not polarised and as
a result trophoblasts become embedded within the matrix. It is
likely that functionally, ﬁbrinoid deposits serve to retain the
integrity of the newly remodelled vessel and may also form
a basementmembrane uponwhich re-endothelialisation can occur.
Necrotic cell death is seen in the wall of modiﬁed vessels from
normal pregnancies [14] and may be associated with trophoblast
senescence towards the end of pregnancy [108]. The incidence of
ﬁbrinoid necrosis is increased in pathological circumstances such
as pre-eclampsia where it is associated with the sub-endothelial
connective tissue and muscle layers and is related to subsequent
development of acute atherosis [109].
9. Can VSMC phenotype affect vessel remodelling?
VSMC behaviour and phenotype in any vessel will be dictated by
their extent of differentiation. Unlike other muscle cells, VSMC are
not terminally differentiated and can switch between ‘functional’
(contractile) and ‘synthetic’ (proliferative) phenotypes accompa-
nied by changes in the expression of multiple genes [110]. In
a healthy adult artery the majority of the VSMC exhibit a contractile
phenotype expressing speciﬁc contractile proteins such as smooth
muscle a-actin, smooth muscle myosin heavy chain, calponin, and
smooth muscle 22a (SM22a). These cells do not generally prolif-
erate, migrate, or secrete signiﬁcant amounts of extracellular
matrix [111]. However, in response to changes in extracellular cues
they can adopt a more synthetic phenotype where the synthesis of
components of the extracellular matrix as well as MMPs can alter.
The synthetic phenotype is often, but not always, coupled with
increasedmigration and proliferation [112] but is always associated
with a loss or reduction in the expression of SMC-speciﬁc
contractile proteins. In regard to spiral artery remodelling a change
in VSMC phenotype could result in an increase in the sensitivity to
apoptotic stimuli [113,114] or increased migration away from the
vessel; indeed de-differentiation of VSMC is known to increase
their migratory potential [79]. Loss of a contractile phenotype is
associated with altered vessel wall structure, including loss of thelayered organisation of VSMC, migration away from the lumen and
loss of differentiation markers in other examples of vascular
remodelling such as atherosclerosis [79,115].
The differentiated state of a VSMC is dependent on a number of
external factors including neighbouring cells and the ECM [116,117].
EC promote VSMC differentiation, stimulating the expression of
contractile proteins [118], and at the same time inhibit both VSMC
matrix deposition and proliferation [119], in part mediated by the
signalling molecule nitric oxide (NO). Trophoblasts can release key
inﬂammatory cytokines including TNFa which together with IL-1b
could stimulate the expression of the inducible form of nitric oxide
synthase (iNOS) in VSMC, which could result in increased VSMC
apoptosis [120].
10. Haemodynamic inﬂuences on vessel structure and
remodelling
The interactions between the EC and VSMC are inﬂuenced by
both mechanical factors such as shear stress and pressure and
paracrine and autocrine signals. These signals are derived either
from within the vessel wall itself or the surrounding tissue and
affect fundamental cellular properties such as the state of differ-
entiation and cell survival. Disturbance of these interactions,
either as a result of the haemodynamic changes that may
accompany pregnancy, or the presence of invading trophoblasts
could have a role to play in the remodelling that takes place.
Although these issues are only just beginning to be addressed in
regard to spiral artery remodelling there is already a substantial
literature concerning the effect of these factors on vessels in other
vascular beds.
The haemodynamic changes that take place in spiral arteries
undergoing transformation are considerable. Formation of the
endovascular trophoblast plug in the ﬁrst few weeks of gestation
[121] will dramatically reduce blood ﬂow in these vessels and at the
same time increase the transmural pressure. As the pregnancy
progresses, the pressure within the plugged vessel will fall as the
VSMC in the myometrial segments lose their structured organisa-
tion, a process that correlates with interstitial trophoblast density
[5]. With the loss of integrity of the plug the ﬂow of blood to the
intervillous space increases as does the shear stress experienced by
the vessel wall.
How such haemodynamic changes might inﬂuence spiral artery
remodelling has not been established, however, the effect of
retrograde blood ﬂow on endovascular trophoblast migration and
invasion has been discussed [122]. It is highly likely that the
response of vascular cells to invading trophoblasts is modulated by
the haemodynamic stresses placed upon them. As remodelling
progresses throughout gestation these stresses change and so,
therefore, will the remodelling response. Evidence from other
vascular systems illustrate the profound effect that mechanical
forces can have on the structure of a vessel by signiﬁcantly altering
EC and VSMC differentiation, growth [123] and response to external
mediators. Physiological levels of shear stress inhibit endothelial
apoptosis induced by a number of stimuli including TNFa and
oxygen radicals [124,125]. It is, therefore, possible that the loss of
laminar ﬂow following trophoblast plugging of the spiral artery
could increase EC susceptibility to trophoblast-mediated apoptotic
stimuli. Haemodynamic forces also inﬂuence interactions between
cells of the vessel wall: for instance EC modulate VSMC phenotype
which affects matrix deposition [126] whereas VSMC can inﬂuence
the EC response to shear stress [127,128]. Although the VSMC may
also be inﬂuenced by shear stress, they are exposed more to
mechanical stretch. In many vessels including the unmodiﬁed
spiral artery this will be experienced in pulses. Unlike EC, the effect
this stimulus has on VSMC proliferation and apoptosis is less clear-
Fig. 1. Diagram of possible mechanisms involved in trophoblast-dependent spiral artery remodelling. Prior to remodelling low-ﬂow, high-resistance spiral arteries are maintained
in a stable state by interactions and signalling between endothelial cells (EC), the extracellular matrix (ECM) and vascular smooth muscle cells (VSMC). The decidualisation process
causes EC vacuolation and VSMC swelling (not shown); however, the major changes to vessel structure occur after extravillous trophoblast reach the vessel. Trophoblasts invading
interstitially would interact with VSMC ﬁrst while endovascular trophoblasts would initially encounter EC in the vessel lumen. Trophoblasts can produce pro-apoptotic factors
which can induce vascular cell apoptosis. Apoptotic cells may then be rapidly removed by professional phagocytes such as macrophages or other cells, such as trophoblasts, which
also possess phagocytic activity. Proteolytic enzymes produced by trophoblasts and vascular cells can inﬂuence the composition of the ECM proteins important in maintaining
vessel integrity. In particular matrix metalloproteinases (MMP) can be produced by trophoblasts and their production by VSMC can be regulated by trophoblasts. Loss of adhesive
interactions between vascular cells and the remodelled ECM could then lead to vascular cell apoptosis. Changes in the ECM or signals from trophoblasts may inﬂuence the state of
differentiation of VSMC by promoting a switch from a contractile to a more synthetic, proliferative phenotype, which may also be accompanied by increased migratory activity and
sensitivity to pro-apoptotic factors. Haemodynamic factors and the presence of decidual natural killer cells will also play a role in the regulation of remodelling (not shown). The
high-ﬂow, low-resistance remodelled vessel will consist of trophoblasts embedded in a ﬁbrinoid material as a replacement for the VSMC. The endothelium is temporarily replaced
with a trophoblast layer, although it is restored later in pregnancy.
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degree of VSMC differentiation [129,130].
11. Role of natural killer cells in vessel remodelling
Decidualisation is associatedwith a large inﬁltration of maternal
natural killer cells with a speciﬁc phenotype that distinguishes
them from peripheral blood NK cells. These cells are present at
a time when spiral artery remodelling is occurring and then
decrease in number from mid-gestation [131]. These decidual NK
(dNK) cells form the major component of immune cells within the
decidua basalis (approximately 70%) with macrophages forming
the next most abundant immune cell type (20e30%) followed by
a low number of T cells. Immunohistochemical studies in humans
suggest that some of these dNK are localised near the decidual
regions of maternal spiral arteries [132]. However, NK cells are
absent in the inner myometrium hence remodelling in this area is
unlikely to be affected by these cells [133].
In addition to roles in interacting with extravillous trophoblast
and in cytokine secretion (reviewed by Tabiasco et al. [134])
studies in mice have indicated involvement of dNK cells in the
regulation of spiral artery remodelling. Ashkar et al. [135]
demonstrated that mice depleted of dNK cells show inadequate
spiral artery remodelling a process regulated, at least in part, by
production of interferon-g (IFNg). This has yet to be elucidated in
humans but, if it is the case, then at least two possibilities exist to
explain how dNK/IFNg could affect vascular cells. There could be
a direct effect from a dNK-derived factor on the vascular cells
(perhaps IFNg, but not necessarily the only factor) or, as there isconsiderable cross-talk between extravillous trophoblasts and
dNK cells, dNK may regulate the trophoblast-induced remodelling
events. Studies in humans have shown that dNK cells can produce
other cytokines in addition to IFNg including TNF-a, leukaemia
inhibitory factor (LIF), CSF-1 and IL-8 [136,137]. IFNg can cause
both proliferation and apoptosis of VSMC [138]; events of impor-
tance to remodelling in other vascular beds and to the develop-
ment of arteriosclerotic lesions. IFNg can act to prime VSMC for
death-receptor induced apoptosis [139], which could be relevant
to spiral artery remodelling given the local environment of pro-
apoptotic factors produced by trophoblast and, in the case of TNFa,
additionally by dNK cells. In addition, IFNg can increase TRAIL
production by trophoblast [140]. Decidual NK cells can produce
many MMPs which could degrade the matrix proteins as discussed
above [83], thus affecting vessel stability, as well as IFNg modu-
lating ECM protein production directly [141]. Recent immunohis-
tochemical studies relating the localisation of immune cells (dNK
and macrophages) with the stage of spiral artery remodelling
suggest that the immune cells may have a role in earlier stages
causing the disorganisation of vascular cells and separation of
smooth muscle layers prior to the arrival of the interstitial and
endovascular trophoblast [13].
Human dNK cells can also produce a variety of angiogenic
factors, including VEGF, placental growth factor (PLGF) and angio-
poietin-2 (Ang-2) [137]. There may well be parallels between the
regulation of angiogenesis, deﬁned as the remodelling of an exist-
ing vascular network, with the events seen in spiral artery
remodelling, although the direct involvement of these factors has
yet to be determined.
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involved in spiral artery remodelling
So far the various mechanisms that might be involved in spiral
artery remodelling have primarily been considered in isolation of
each other. However, it is clear that a number of these mechanisms
are interdependent (summarised in Fig. 1). In many vascular beds
the sensitivity of VSMC to apoptotic stimuli is inﬂuenced by factors
that alter their state of differentiation, which is in turn inﬂuenced
by the composition of the ECM and signals derived from the EC. The
way EC behave will be determined by signals from the VSMC and
the ECM on one side and the physico-mechanical stresses of shear
and stretch on the other. All these factors and more will inﬂuence
how these cells within the vessel respond not only to the invading
trophoblasts but also the inﬁltrating maternal immune cells.
It is also apparent that differentiation will affect the synthesis
and release of proteolytic enzymes. This will change the composi-
tion of the ECM and this in turnwill alter the signals received by the
vascular cells which will further inﬂuence their differentiated state.
Loss of the endothelium as a result of trophoblast invasion will also
have a direct effect on VSMC differentiation and survival through
the loss of important survival and differentiation signals, perhaps
making them more sensitive to the apoptotic signals released by
trophoblasts. In addition to vascular cell apoptosis, migration of
VSMC away from the vessel may provide another mechanism for
the reduction of VSMC associated with the remodelled spiral artery,
although this hypothesis requires further investigation.
In recent years the processes involved in the crucial pregnancy
adaptation of spiral artery remodelling have begun to be eluci-
dated. Many groups have developed novel approaches to model
these events in vitro which, in combination with previous histo-
logical studies, are giving insights into the regulation of spiral
artery remodelling. Continued research in the placental ﬁeld
combined with lessons learnt from studies in other vascular beds
will allow the exact role of trophoblast-dependent and -indepen-
dent changes to be determined. It is only when we have a clearer
picture of the events occurring in a normal pregnancy that we can
begin to determinewhich of these are compromised in pregnancies
complicated by disorders such as pre-eclampsia.Acknowledgements
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